Clonidine Tablet, Extended Release
Product Images NDC 52817-375

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 52817-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Sp Lm 031 V00)

Label (Sp Lm 031 V00)
Label for Clonidine extended-release tablets, 0.17 mg strength. The label shows 30 tablets per container and includes storage instructions (20°-25°C, with permitted excursions), dispensing advice, and a child-resistant container warning. Distributed by TruPharma, LLC, Tampa, FL. Contains the NDC number 52817-375-30 and a barcode.*
FDA Label Image

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)

Molecularstructure (Nexiclon Clonidine Extended Release Tablet 1)
Chemical structure of Clonidine hydrochloride, showing its chlorinated aromatic ring and imidazoline ring components, as depicted in a skeletal formula with attached hydrochloride (HCl).*
FDA Label Image

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)

Figure1 (Nexiclon Clonidine Extended Release Tablet 2)
A line graph depicting mean concentration (pg/mL) over time (hours) for three variables labeled A, B, and C. The graph shows concentration increasing rapidly before decreasing in a multi-phasic pattern for variable B, with variables A and C following a similar rising and falling trend over 72 hours.*
FDA Label Image

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)

Figure2 (Nexiclon Clonidine Extended Release Tablet 3)
A line graph depicting systolic and diastolic blood pressure (mmHg) over time (hours) up to 24 hours in a sitting position. The graph compares two treatment regimes: 0.6 mg extended-release (ER) and 0.3 mg twice daily immediate-release (BID IR) Clonidine. Lines distinguish systolic and diastolic measurements for each dosage form over the specified time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.